Breaking News
October 18, 2018 - From Biopsy to Diagnosis
October 18, 2018 - Sexual harassment and assault linked to worse physical/mental health among midlife women
October 18, 2018 - Stumped by medical school? A Q&A with a learning specialist
October 18, 2018 - Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation
October 18, 2018 - FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
October 18, 2018 - Many U.S. adults confused about primary care, study shows
October 18, 2018 - With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center
October 18, 2018 - Mice study shows antibiotics are not always necessary to cure sepsis
October 18, 2018 - Researchers discover why heart contractions are weaker in individuals with HCM
October 18, 2018 - Participation in organized sport during childhood may have long-term skeletal benefits
October 18, 2018 - Probiotic/antibiotic combination could eradicate drug-resistant bacteria
October 17, 2018 - More Socioeconomic Challenges for Hispanic Women With HIV
October 17, 2018 - 49,XXXXY syndrome – Genetics Home Reference
October 17, 2018 - Scientists uncover possible new causes of Tourette syndrome
October 17, 2018 - Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
October 17, 2018 - Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
October 17, 2018 - Elective induction of labor at 39 weeks may be beneficial option for women and their babies
October 17, 2018 - New smart watch algorithms can accurately monitor wearers’ sleep patterns
October 17, 2018 - Researchers demonstrate epigenetic memory transmission via sperm
October 17, 2018 - FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
October 17, 2018 - Health Tip: Know the Risks of Chicken Pox
October 17, 2018 - Immunotherapy effective against hereditary melanoma
October 17, 2018 - Researchers reveal new mechanism for how animal cells stay intact | News Center
October 17, 2018 - Alzheimer's Goes Under the Cryo-Electron Microscope
October 17, 2018 - Medicare for all? CMS chief warns program has enough problems already
October 17, 2018 - Metrohm Raman introduces Mira P handheld Raman system
October 17, 2018 - Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
October 17, 2018 - Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
October 17, 2018 - Many healthy children may have metabolic risk factors, finds study
October 17, 2018 - A new antibiotic could be a better, faster treatment for tuberculosis
October 17, 2018 - “I will not become a Robot Doctor”: A medical student vows to practice compassion
October 17, 2018 - Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
October 17, 2018 - Purdue researchers develop new chemical process to find better drug ‘fits’ for patients
October 17, 2018 - Yale researchers develop way to attack RNA with small-molecule drugs
October 17, 2018 - New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug
October 17, 2018 - Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
October 17, 2018 - Nine cases of polio-like illness suspected in children in illinois
October 17, 2018 - Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries
October 17, 2018 - Patients once thought incurable can benefit from high-dose radiation therapy
October 17, 2018 - Researchers awarded grant to advance testing of experimental heroin vaccine
October 17, 2018 - Researchers examine SSRI use during pregnancy and major gestational malformations
October 17, 2018 - FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T
October 17, 2018 - Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment
October 17, 2018 - Study reveals link between childhood abuse and higher arthritis risk in adulthood
October 17, 2018 - Research shows people over 65 are not performing enough physical activity
October 17, 2018 - FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
October 17, 2018 - Weight gain after smoking cessation linked to increased short-term diabetes risk
October 17, 2018 - Researchers find opportunity to control salt-sensitive hypertension without exercising
October 17, 2018 - Women not warned about cancer associated with breast implants
October 17, 2018 - Metrohm offers robust handheld Raman analyzer for Defense and Security
October 17, 2018 - Modeling Non-Numerical Data in Systems Biology
October 17, 2018 - Research aims to address health disparities in African-American men
October 17, 2018 - Human and cattle decoys trap outdoor-biting mosquitoes in malaria endemic regions
October 17, 2018 - High Circulating Prolactin Level Inversely Linked to T2DM Risk
October 17, 2018 - Study finds gene variant predisposes people to both Type 2 diabetes and low body weight
October 17, 2018 - Metrohm software products make it easy to comply with ALOCA and ALCOA+ guidelines
October 17, 2018 - Network of doctors identify the cause of 31 new conditions
October 17, 2018 - Notable improvement in brain cancer survival among younger patients but not much for elderly
October 17, 2018 - Scientists shed light on roles of transcription factors, TP63 and SOX2, in squamous cell carcinoma
October 17, 2018 - Costs of Medicare Diabetes Prevention Program may be higher than expected reimbursement
October 17, 2018 - Misuse of prescription opioids or benzodiazepines associated with suicidal thoughts
October 17, 2018 - New research seeks to address sex disparities in women’s health
October 17, 2018 - C-Section Rates Have Nearly Doubled Since 2000: Study
October 17, 2018 - Talking to Your Kids About STDs
October 17, 2018 - New classification of periodontal and peri-implant diseases and conditions
October 17, 2018 - Herbert D. Kleber, Pioneer in Addiction Treatment, Dies at 84
October 17, 2018 - Health effects of smoke-filled atmosphere
October 17, 2018 - Down syndrome may hold important clues to onset of Alzheimer’s disease
October 17, 2018 - A special report on US’ aging societies
October 17, 2018 - Birth mode may have acute effects on neurodevelopment, study suggests
October 17, 2018 - Global health innovation system fails to deliver affordable treatments to patients, says report
October 17, 2018 - Simple, inexpensive test quickly detects antibiotic-resistant ‘superbugs’
October 17, 2018 - New drugs could reduce risk of heart disease when added to statins
October 17, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum
October 17, 2018 - HVP vaccination not linked with rise in teen risky sex
October 17, 2018 - Potential ‘early warning markers’ for sepsis discovered
October 17, 2018 - Who knew? Life begins (again) at 65
October 17, 2018 - Application of blood pressure guidelines ups treatment
October 17, 2018 - Stanford researchers find that small molecule may help treat enzyme deficiency
October 17, 2018 - Speed Cameras Save Money and Lives in New York City
New genome editing tool used to heal genetic disease

New genome editing tool used to heal genetic disease

image_pdfDownload PDFimage_print

Parents of newborns may be familiar with the metabolic disorder phenylketonuria: in Switzerland, all newborn babies are screened for this genetic disease. If a baby is found to have phenylketonuria, it needs a special diet so that the amino acid phenylalanine does not accumulate in the body. Excess phenylalanine delays mental and motor development. If left untreated, the children may suffer massive mental disability.

The cause of this metabolic disorder is a mutation in a gene that provides the blueprint for the enzyme phenylalanine hydroxylase (Pah). This enzyme, which is produced by the cells of the liver, metabolizes phenylalanine. The disorder is referred to as “autosomal recessive”: the child develops the disease if it inherits one mutated gene from the mother and one from the father. There has been no cure for this disorder to date.

Enhancement of the CRISPR/Cas9 system

A team of researchers led by ETH professor Gerald Schwank has now taken advantage of a method to correct both mutated genes in the liver cells and thus heal the disease. They have succeeded, at least in mice.

With the help of a CRISPR/Cas9 system extended by one enzyme, the researchers changed the sequence of the DNA building blocks for the corresponding gene in adult mice. The liver cells were subsequently able to produce functioning Pah enzymes, and the mice were healed.

Let’s look at the details: The CRISPR/Cas9 system enhanced by the enzyme cytidine deaminase binds to the locus on the gene that needs to be corrected and locally opens both DNA strands. The deaminase converts the disease-causing DNA base pair C-G into T-A, which is the base pair that occurs at that spot in healthy individuals. This corrects the error in the DNA sequence of the Pah enzyme.

In traditional CRISPR/Cas editing, inducing a DNA double-stranded break is the central element of genome editing. The double strand is cut at a defined point, and the cell attempts to repair the cut using various mechanisms. If a matching DNA sequence is added to the cell from outside, it enables a specialized repair mechanism to precisely modify the specific genetic sequence.

The problem here is that most human cells primarily use other DNA repair mechanisms that produce additional undesired mutations.

More sparing genome editing

The researchers realized that the new genome editing tool is much more efficient than the traditional CRISPR/Cas9 method: up to 60 percent of all copies of the gene with errors in the mouse liver were corrected. This resulted in the concentration of phenylalanine falling to normal levels, and the animals no longer showing any signs of the disorder after being treated with the genome editing tool.

To transfer the genetic code for the new editing tool to the liver cells, the researchers implanted the required genes into adeno-associated viruses and injected them into the blood of the mice. The virus then infected the liver cells, thereby introducing the genes for the editing tool into the liver cell.

Healing other metabolic diseases

“This approach has great potential for application in humans”, says Gerald Schwank. However, this study is only a first proof of concept. Clinical studies in other animal models would have to follow in order to test the efficacy and safety of the new genome editing tool for application in humans.

Previous methods of genome editing have only limited success at correcting target mutations directly in animals. The correction rate in the liver of adult mice has previously been only a few percent, explains Schwank. “Here we’ve achieved several fold higher editing rates – nobody has managed that so far.”

Schwank considers the risks to be low. After applying the editing tool in the mouse model the researchers looked for non-target mutations, that is, on sites where there shouldn’t be mutations. But they didn’t find any. Schwank would like to examine this more closely in a follow-up study. &laquoThe human liver consists of several billion cells. In none of them we want to induce any mutations that could cause cancer», emphasizes Schwank. Testing is also needed to find out whether the adeno-associated virus used by the researchers as a vehicle for applying the editing tool gene causes any adverse effects.

Focus on further metabolic disorders

“The use of a base editor was the key to our success”, explains Schwank’s doctoral candidate and primary author of the study, Lukas Villiger. They were developed at the Massachusetts Institute of Technology (MIT) and presented just two years ago in a scientific journal. Before that, the ETH researchers had been working with traditional CRISPR/Cas approaches. In 2016, Schwank and Villiger starting using the techniques developed by the US researchers. “Even with the new base editors, the path still didn’t follow a straight line – we had to tinker around quite a bit”, says Villiger. The biggest surprise was that this system is so much more effective than the traditional CRISPR/Cas toolbox.

Schwank is now looking for funding to conduct trails on other animal models such as pigs. “The liver of the mouse differs in size and structure from that of humans or pigs, so we definitely have to expand the scope of our trials to other organisms to make progress.”

Phenylketonuria is not the only genetic metabolic disorder that affects the liver. For example, urea cycle disorders prevent the body from removing ammonia (as a by-product from foods containing nitrogen) from the blood and metabolizing it to urea. This results primarily in central nervous dysfunctions. The only currently available option to cure this disease is liver transplantation. Therefore, Schwank would like to test the newly developed genome editing tool for use in such diseases as well.

Source:

https://www.ethz.ch/en/news-and-events/eth-news/news/2018/10/erbkrankheit-mittels-genkorrektur-geheilt.html

Tagged with:

About author

Related Articles